John B Kisiel

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Electronic address
    Clin Gastroenterol Hepatol 14:1778-1787.e8. 2016
  2. pmc New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Cancer Res 21:4473-81. 2015
  3. pmc Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA
    Dig Dis Sci 59:1764-7. 2014
  4. pmc Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
    J B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Aliment Pharmacol Ther 37:546-54. 2013
  5. pmc Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Inflamm Bowel Dis 19:2079-83. 2013
  6. pmc Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Cancer 118:2623-31. 2012
  7. pmc DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance
    David H Johnson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Department of Internal Medicine, Rhode Island Memorial Hospital, Pawtucket, Rhode Island Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota and Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
    Inflamm Bowel Dis 22:1559-67. 2016
  8. doi request reprint Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy
    Parakkal Deepak
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastrointest Endosc 83:1005-12. 2016
  9. doi request reprint Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening
    David H Johnson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc . 2016
  10. doi request reprint Endoscopic overestimation of colorectal polyp size
    Bradley W Anderson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 83:201-8. 2016

Collaborators

Detail Information

Publications14

  1. pmc Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Electronic address
    Clin Gastroenterol Hepatol 14:1778-1787.e8. 2016
    ..We simulated these strategies for CRN detection to determine which approach is most cost-effective...
  2. pmc New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Clin Cancer Res 21:4473-81. 2015
    ..Discriminant markers for pancreatic cancer detection are needed. We sought to identify and validate methylated DNA markers for pancreatic cancer using next-generation sequencing unbiased by known targets...
  3. pmc Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA
    Dig Dis Sci 59:1764-7. 2014
    ..Molecular changes associated with colorectal cancer (CRC) are detected by stool deoxyribonucleic acid testing but could persist following tumor resection...
  4. pmc Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
    J B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Aliment Pharmacol Ther 37:546-54. 2013
    ..Current approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (IBD-CRN) are suboptimal...
  5. pmc Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Inflamm Bowel Dis 19:2079-83. 2013
    ..It is not known if mEYA4 is also present in nonadjacent non-neoplastic mucosa (NNM) of UC patients with colorectal neoplasia...
  6. pmc Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Cancer 118:2623-31. 2012
    ..Aberrantly methylated genes are unexplored as markers for noninvasive detection by stool testing. The authors aimed to select discriminant methylated genes and to assess accuracy of these and mutant KRAS in stool to detect PanC...
  7. pmc DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance
    David H Johnson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota Department of Internal Medicine, Rhode Island Memorial Hospital, Pawtucket, Rhode Island Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota and Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
    Inflamm Bowel Dis 22:1559-67. 2016
    ....
  8. doi request reprint Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy
    Parakkal Deepak
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Gastrointest Endosc 83:1005-12. 2016
    ..Chromoendoscopy (CE) identifies dysplastic lesions with a higher sensitivity than white-light endoscopy (WLE). The role of CE in the management of dysplasia on surveillance WLE in inflammatory bowel disease (IBD) remains unclear...
  9. doi request reprint Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening
    David H Johnson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc . 2016
    ..We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality...
  10. doi request reprint Endoscopic overestimation of colorectal polyp size
    Bradley W Anderson
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 83:201-8. 2016
    ..We sought to compare contemporary assessments of polyp size by endoscopic estimation and pathology measurement...
  11. pmc Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes
    Jeffrey D McCurdy
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    Inflamm Bowel Dis 19:2394-9. 2013
    ..Here, we report our experience with CMV involvement of the pouch, including risk factors, clinical features, and pouch outcomes in patients with inflammatory bowel disease after proctocolectomy with ileal pouch-anal anastomosis...
  12. doi request reprint Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Gastroenterol 45:301-8. 2011
    ..This review briefly examines the early cost-effectiveness estimates for stool DNA screening and looks ahead at how the next generation tests might improve such value estimates for CRC screening...
  13. doi request reprint Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy
    John B Kisiel
    Division of Gastroenterology and Hepatology, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:226-35. 2012
    ..Ulcerative colitis (UC) patients are at increased risk of colorectal dysplasia and cancer. Few studies have examined the clinical outcomes of dysplastic polyps resembling sporadic adenomas that are removed with endoscopic polypectomy...
  14. pmc Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis
    John B Kisiel
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 110:1473-4. 2015
    ..Long-term follow-up of many, well-phenotyped, low-grade dysplasia cases sheds new light, and raises new questions, on our UC surveillance practice. ..